Simbol | YTM % | Volum | Harga % | Kupon % | Tarikh Matang | Jumlah tertunggak | Nilai muka | Jumlah denominasi min | Pengeluar |
---|---|---|---|---|---|---|---|---|---|
RPHC5222528Royalty Pharma plc 3.35% 02-SEP-2051 | 7.47% | 71 K | 63.26% | 3.35% | 2051-09-02 | 700 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237919Royalty Pharma plc 3.55% 02-SEP-2050 | 7.26% | 2.91 M | 66.72% | 3.55% | 2050-09-02 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237891Royalty Pharma plc 3.3% 02-SEP-2040 | 6.92% | 260 K | 72.76% | 3.30% | 2040-09-02 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5824522Royalty Pharma plc 5.9% 02-SEP-2054 | 6.34% | 4.47 M | 95.49% | 5.90% | 2054-09-02 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5222527Royalty Pharma plc 2.15% 02-SEP-2031 | 5.81% | 274 K | 82.34% | 2.15% | 2031-09-02 | 600 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5824521Royalty Pharma plc 5.4% 02-SEP-2034 | 5.77% | 572 K | 97.70% | 5.40% | 2034-09-02 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237916Royalty Pharma plc 2.2% 02-SEP-2030 | 5.71% | 3.38 M | 84.91% | 2.20% | 2030-09-02 | 996.81 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5824520Royalty Pharma plc 5.15% 02-SEP-2029 | 5.17% | 5.2 M | 99.92% | 5.15% | 2029-09-02 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237354Royalty Pharma plc 1.75% 02-SEP-2027 | 5.11% | 260 K | 92.03% | 1.75% | 2027-09-02 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5237914Royalty Pharma plc 1.2% 02-SEP-2025 | 4.94% | 908 K | 97.47% | 1.20% | 2025-09-02 | 999.96 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5035520Royalty Pharma plc 2.2% 02-SEP-2030 | 2.37% | 0 | 98.72% | 2.20% | 2030-09-02 | 3.19 M USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |
RPHC5035516Royalty Pharma plc 1.2% 02-SEP-2025 | 1.30% | 0 | 99.62% | 1.20% | 2025-09-02 | 38 K USD | 1,000.00 USD | 2,000.00 USD | Royalty Pharma Plc |